RNAi therapeutics

Related by string. RNAi therapeutic * RNAI : comprise Alnylam RNAi / Therapeutics : small molecule therapeutics * novel RNAi therapeutics . RNA interference RNAi therapeutics . delivered RNAi therapeutic . RNAi therapeutic targeting . systemic RNAi therapeutic . inventing RNAi therapeutics . Alnylam RNAi therapeutics . RNAi therapeutic platform . RNAi therapeutic targeting PCSK9 *

Related by context. All words. (Click for frequent words.) 70 siRNA delivery 67 RNAi 67 RNAi therapeutic 65 novel RNAi therapeutics 65 therapeutics 64 siRNA therapeutics 64 protein therapeutics 63 microRNA therapeutics 62 immunotherapeutics 62 cancer therapeutics 61 therapeutic antibodies 61 small molecule 61 siRNA compounds 61 Inc. Nasdaq ALNY 60 CAMBRIDGE Mass. Alnylam Pharmaceuticals 60 antisense drugs 60 Alnylam 59 RNAi therapeutic targeting 59 oncology therapeutics 59 novel therapeutics 59 small molecule therapeutics 59 Nanobody 58 stem cell therapeutics 58 antisense 58 rxRNA compounds 58 exon skipping 58 immunotherapeutic 58 anticancer agents 58 selective androgen receptor modulators 58 ALN PCS 58 NovaBay Aganocide compounds 58 disease modifying 58 LNPs 58 ocular diseases 58 RNA interference RNAi therapeutics 58 SNALP 57 antagomirs 57 Novosom 57 systemic RNA interference 57 monoclonal antibodies 57 Fleximer 57 inflammatory diseases 57 aptamer therapeutics 57 Dicer Substrate Technology 57 KineMed 57 Adnectin 57 antisense drug 57 antibody therapeutics 57 biologic therapeutics 57 siRNA therapeutic 56 DiLA2 56 therapeutic monoclonal antibodies 56 JAK1 56 histone methyltransferases HMTs 56 immunotherapies 56 biologic therapies 56 biotherapeutics 56 IAP inhibitors 56 systemic RNAi 56 Guanilib 56 HCV protease inhibitor 56 LNP formulations 56 renin inhibition promising 56 Nanobody ® 56 antiviral therapeutics 56 RNA antagonists 56 RNA therapeutics 55 DsiRNA 55 rxRNA 55 Nanobodies R 55 AtuRNAi 55 vascular disrupting agents 55 Viprovex TM 55 MEK inhibitors 55 Nanobodies 55 siRNA 55 Stapled Peptide 55 therapeutic monoclonal antibody 55 oligonucleotide therapeutics 55 novel anti infective 55 molecularly targeted 55 cancer immunotherapies 55 Celator 55 MediVas 55 adrenal steroid hormones 55 regenerative medicine 55 RONDEL ™ 55 HCV polymerase inhibitors 55 NTDDS 55 Sphingomab 55 immunomodulatory 55 Ambrx 54 Kleanthis G. Xanthopoulos Ph.D. 54 preclinical 54 ALN TTR# 54 peptide therapeutics 54 antiviral compounds 54 investigational therapies 54 Nasdaq ALNY 54 therapeutic antibody 54 ALN VSP 54 small molecule inhibitors 54 stable nucleic acid 54 antisense oligonucleotides 54 Panzem R 54 Applied NeuroSolutions 54 Regulus Therapeutics 54 RNA interference RNAi 54 Metallophile ™ Technology 54 #ME# 54 anticancer therapies 54 cancer immunotherapy 54 Archexin 54 SARMs 54 EndoTAG TM 54 neurodegenerative diseases 54 Inc. Nasdaq RNAI 54 Adenosine Therapeutics 54 LentiVector technology 54 PEGylation technology 54 FGFR 54 JAK inhibitors 54 Stapled Peptides 54 proteasome inhibitors 54 Tarvacin TM 54 humanized antibodies 54 immunotherapy 54 selective kinase inhibitors 54 CNS disorders 54 preclinical studies 53 Cellzome 53 novel peptides 53 proprietary Dicer Substrate Technology 53 deforolimus 53 ALN TTR 53 immuno inflammatory diseases 53 hematological cancers 53 Inc. OTCBB LPTN 53 DOS# 53 delivered RNAi therapeutic 53 isoform selective 53 Quark Biotech Inc. 53 prostone 53 AtuPLEX 53 NNR Therapeutics 53 Dicerna 53 optimized siRNA 53 proprietary PEGylation 53 kinase inhibitors 53 Nanobodies ® 53 Serdaxin 53 renin inhibitors 53 AP# [003] 53 Curaxins 53 live attenuated Listeria 53 TREANDA 53 lipid nanoparticle 53 epigenetic enzymes 53 sirtuin therapeutics 53 tiapamil 53 nanomedicine 53 therapeutic 53 tkRNAi 53 Rib X 53 monoclonal antibody therapeutics 53 polymerase inhibitors 53 Curaxin 53 targeting PCSK9 53 oncolytic viruses 53 anticancer compounds 53 FluoroPharma 53 CCR9 antagonist 53 Isis antisense 53 immunotherapeutic approaches 53 companion diagnostics 53 renin inhibition 53 nanomedicines 53 molecular biomarkers 53 antisense therapeutics 53 biotherapeutic 53 therapeutic proteins 53 Nasdaq MBRX announced 53 ophthalmic therapeutics 53 Cobalamin 53 targeted radiotherapeutic 53 novel peptide 53 monoclonal antibody 52 Fleximer R 52 siRNA sequences 52 Homspera 52 BCR ABL inhibitors 52 PLK1 SNALP 52 TLR9 agonists 52 regenerative medicine therapies 52 novel immunomodulatory 52 vaccines oncolytic virus 52 Chemokine Therapeutics 52 delta isoform 52 MDRNA proprietary 52 Azedra 52 anti infective 52 vascular disrupting agent 52 NexACT 52 Homspera TM 52 SGLT inhibitors 52 therapies 52 Intellikine 52 TPI ASM8 52 HCV protease inhibitors 52 AAV vectors 52 unmet medical 52 Ceflatonin 52 RNAi molecules 52 MEK inhibitor 52 JAK2 inhibitor 52 Alnylam #x# 52 Combivir Kivexa 52 Dr. Aiping Young 52 talactoferrin 52 liposomal 52 pharmacological chaperone 52 DPX Survivac 52 siRNAs 52 Panzem 52 RNA antagonist 52 ArQule Kinase Inhibitor Platform 52 anticoagulant reversing agent 52 lipid nanoparticles 52 A3 adenosine receptor 52 CORT # 52 FoldRx 52 topical dermatology 52 rxRNA TM compounds 52 biomarker discovery 52 synthetic retinoid 52 DiLA2 Platform 52 Aganocide ® 52 HepDirect 52 CBLC# 52 pharmacogenetics 52 NYSE Amex RNN 52 deacetylase inhibitors 52 NEUGENE R 52 iPSC technology 52 clinically validated targets 52 PEGylation 52 LentiVector 52 Omacetaxine 52 small molecule defensin 52 NASDAQ ALNY 52 SNALP technology 52 PI3K/Akt pathway inhibitor 52 immuno oncology 52 PARP inhibitors 52 Anticalin 52 anti angiogenic drugs 52 PEGylated 52 GammaCan 52 TLR Therapeutics 52 Epothilones 51 Nasdaq ENZN 51 Neogenix 51 humanized monoclonal antibodies 51 otelixizumab 51 Lpath 51 Nasdaq VRTX 51 intranasal delivery 51 Affibody 51 anti angiogenesis 51 Receptos 51 AMPAKINE compounds 51 Regado Biosciences 51 sd rxRNA 51 small interfering RNAs 51 immune modulation 51 immunologic diseases 51 molecular chaperone amplification 51 Hybridon 51 neurodegenerative disorders 51 Etubics 51 ddRNAi 51 PRNewswire FirstCall Sirna Therapeutics 51 PharmFilm ® 51 SR Pharma 51 epothilones 51 Locked Nucleic Acid 51 SCYNEXIS 51 Isis Pharmaceuticals 51 Oracea TM 51 regenerative therapeutics 51 immune modulatory 51 ASONEP TM 51 Hsp# inhibitor 51 JAK inhibitor 51 aTyr Pharma 51 Bioral 51 nitric oxide donating 51 liposomal delivery 51 ophthalmic pharmaceutical 51 VitiGam 51 Tekmira lipid nanoparticle 51 PNT# 51 DAVANAT R 51 immatics 51 diseases fat malabsorption 51 using ImmunoGen TAP 51 chronic inflammatory 51 Sentinel Principle 51 miRNA therapeutics 51 ChemoCentryx 51 MTP inhibitor 51 Calistoga Pharmaceuticals 51 Therapeutic antibodies 51 renin inhibitor 51 GAP #B# 51 HCV protease 51 metabolomics 51 nanoviricides 51 siRNAs targeting 51 sd rxRNA compounds 51 ImmuneRegen BioSciences Inc. 51 chemotherapeutics 51 BioWa 51 histone deacetylase inhibitors 51 Factor VIIa 51 Aegis Therapeutics 51 covering SNALP 51 short interfering RNA 51 autoimmune inflammatory 51 RNAi compounds 51 NASDAQ DYAX 51 anticancer therapy 51 cardio renal 51 fibrotic diseases 51 CUDC 51 EyeGate Pharma 51 oral antiviral 51 Hsp# inhibition 51 mda 7 51 TRAIL receptor antibodies 51 vinca alkaloid 51 aptamers 51 Anacor 51 anticancer drugs 51 proprietary LNA 51 allosteric modulation 51 RNAi Therapeutics 51 antibody therapies 51 novel antibody therapeutics 51 Nasdaq HALO biopharmaceutical 51 novel antiviral therapeutics 51 Nasdaq LXRX biopharmaceutical 51 ApoB SNALP 51 SGLT Inhibitors 51 parenteral administered 51 pan HDAC inhibitor 51 RNAi therapeutic targeting PCSK9 51 Galenea 51 Lycera 51 Abiraterone acetate 51 TLR antagonists 51 Anticalins 51 epigenetic therapies 51 oncology indications 51 ALD# 51 entinostat 51 Nektar PEGylation technology 51 Tranzyme 51 anticancer agent 51 IAP inhibitor 51 HIV protease inhibitor 51 Charlesson 51 molecular chaperone regulation 51 CTLA4 Ig 51 J. Mazzo Ph.D. 51 ZFP technology 51 Litx 51 influenza hypercholesterolemia 51 Nektar pulmonary 51 autologous cellular therapy 50 tranilast 50 OTCBB PYTO FWB ET6 50 L BLP# 50 Unit Dose Budesonide 50 nicotinic alpha 7 50 macrolide antibiotics 50 John Maraganore Ph.D. 50 UsiRNAs 50 NASDAQ ABII 50 histone deacetylase HDAC inhibitors 50 Zalicus 50 AKIP ™ 50 OTCBB CTIX 50 Ablynx 50 punctal plug drug 50 NEUGENE 50 metaglidasen 50 chemically modified siRNA 50 Intravenous CP 50 therapeutic peptides 50 targeting CD# 50 BioSeek 50 Phylomer ® 50 DAVANAT ® 50 fusion proteins 50 Cetrorelix 50 siRNA conjugates 50 LHRH antagonists 50 NASDAQ CYTR biopharmaceutical 50 translational medicine 50 URG# 50 oncolytic 50 IMiDs R 50 oral prodrug 50 oncology 50 liposome formulations 50 KemPharm 50 anticancer therapeutics 50 motexafin gadolinium Injection 50 bevirimat 50 P#X# antagonist 50 Plexxikon 50 investigational compounds 50 epothilone 50 Cyclosert 50 antiviral therapies 50 OncoVEX 50 THR beta agonist 50 tesetaxel 50 regenerative therapies 50 liposomal formulation 50 vaccine adjuvant 50 Semafore 50 p# inhibitor 50 Intarcia 50 oral transdermal 50 antibody fragment therapeutics 50 nucleoside tide analogs 50 G Protein Coupled 50 AMPK activators 50 microRNAs 50 HepDirect R 50 Alnylam Biotherapeutics 50 ophthalmic diseases 50 iSONEP 50 Regado 50 monoclonal antibody therapies 50 RPL# 50 catalytic antioxidant compounds 50 atacicept 50 Alnylam Pharmaceuticals 50 engineered proteases 50 AMEX ONI 50 Fibrocell Science 50 lipid particles 50 Cylene 50 DiLA 2 50 HSP# inhibitor 50 theranostics 50 biopharmaceuticals 50 Avian Transgenic Technology 50 Acetylon 50 NNRs 50 Tarmogen 50 Nasdaq IDRA 50 non nucleoside HCV 50 Inotek Pharmaceuticals Corporation 50 Hedgehog pathway 50 Enkephalin 50 RNA interference 50 ProSavin 50 TSX TKM 50 NASDAQ IMCL 50 metalloenzymes 50 transdermal drug 50 AEG# 50 BiTE 50 CombinatoRx 50 enhance ApoA 50 FOLOTYN ® 50 Epeius Biotechnologies Corporation 50 epigenetics 50 histone deacetylase HDAC 50 AngioChem 50 MOR# 50 XmAb ® 50 PNP inhibitor 50 Vegenics 50 ARRY # 50 NP2 Enkephalin 50 mediate RNAi 50 vivo electroporation 50 Ph.D. Targacept 50 GPCRs 50 humanized anti 50 XmAb# 50 Captisol 50 PDE4 inhibitor 50 OncoVEX GM CSF 50 oxidative stress inducer 50 Pervasis 50 TÎ ² 4 50 molecular imaging 50 neuropathic pain 50 RhuDex ® 50 ZaBeCor 50 commercializing anti infective 50 tyrosine kinase inhibitors 50 Gemin X 50 Karo Bio 50 siRNA molecules 50 Nasdaq RXII 50 anticancer 50 Locked Nucleic Acid LNA 50 Onalta 50 Bioral R 50 novel immunotherapeutic 50 Onconase 50 Tod Woolf Ph.D. 50 novel immunotherapies 50 ProLindac TM 50 PI3K inhibitors 50 Tekmira SNALP technology 50 humanized monoclonal antibody 50 proprietary Biochronomer 50 AAG geldanamycin analog 50 anti CD# antibodies 50 AAV vector 50 antifolate 50 Avila Therapeutics 50 preclinical compounds 50 dAbs 50 novel VDA molecule 50 antisense oligonucleotide 50 Hsp# inhibitors 50 lentiviral vector 50 TIMERx R 50 miRagen 50 orally bioavailable 49 Adrenomyeloneuropathy AMN HIV 49 Liprotamase 49 therapeutic modality 49 Symphogen 49 autoimmune diseases 49 lipidoid 49 systemic siRNA 49 histone deacetylase HDAC inhibitor 49 proteasome inhibitor 49 small molecule agonists 49 Solazed TM 49 IL-#/# 49 angiogenesis inhibitors 49 acting muscarinic antagonist 49 engineered RAP peptides 49 TOPIGEN 49 multitargeted 49 VaxInnate 49 Tarvacin 49 Chrysalin 49 RONDEL TM 49 bionanotechnology 49 melanocortin receptor agonists 49 Cobalamin TM mediated 49 transdermal delivery 49 Viprovex R 49 Friedreich Ataxia FRDA 49 Aerosurf 49 multi kinase inhibitor 49 PRX # 49 NGX# 49 GPCR targets 49 MAXY G# 49 BioSilicon TM 49 AN# novel 49 Sirtris 49 diagnostic biomarkers 49 Aptamers 49 Aeolus Pharmaceuticals 49 nanopharmaceuticals 49 Elesclomol 49 Mipomersen 49 bioactive lipids 49 AKT inhibitor 49 antiangiogenesis therapies 49 Cancer Therapeutics 49 Alnylam RNAi 49 Tolerx 49 Scancell 49 Aganocide 49 DURECT proprietary 49 Nexavar ® 49 tezampanel 49 GPCR 49 Anavex #-# 49 HuLuc# 49 diabetic nephropathy 49 Sudhir Agrawal D.Phil 49 immunological diseases 49 chemotherapeutic drugs 49 NCEs 49 Aganocide R 49 humanized antibody 49 PhaseBio 49 VentiRx 49 INCB# [001] 49 Inc. NASDAQ CRIS 49 investigational humanized monoclonal antibody 49 adrenergic regulation 49 biodefense vaccines 49 novel therapeutic antibodies 49 Anaphore 49 SMaRT ™ 49 ALN HTT 49 ophthalmology oncology 49 kidney urologic 49 Fodosine 49 LymphoStat B 49 anti angiogenic therapy 49 Inc. Nasdaq ACHN 49 Dyax phage display 49 ViiV Healthcare 49 Ceflatonin R 49 Epizyme 49 selective inhibition 49 Soliris eculizumab 49 generation antisense 49 ActivX 49 CB2 selective 49 bluebird bio 49 OXIGON TM 49 NexACT R 49 CINOD 49 Alfacell proprietary ribonuclease 49 RDEA# 49 anti angiogenic 49 nucleic acid lipid 49 COX Inhibiting Nitric Oxide 49 LY# [003] 49 resolvin 49 Angiocept 49 myelofibrosis 49 cyclophilin inhibitors 49 Profectus BioSciences 49 REOLYSIN ® 49 covalent drugs 49 Helix BioMedix 49 mGluR4 mGluR2 mGluR5 49 OHR/AVR# 49 NuMimetic TM 49 human antibody therapeutics 49 NASDAQ SNTA biopharmaceutical 49 Aganocide compounds 49 platinum chemotherapeutic 49 immunoregulation 49 familial amyloidotic polyneuropathy FAP 49 radezolid 49 theranostic 49 Agios Pharmaceuticals 49 HyACT 49 oral taxane 49 Antigen Express 49 Anticalin R 49 Ception Therapeutics 49 neuroprotective properties 49 liver cancers hypercholesterolemia 49 CYT# potent vascular disrupting 49 SYGNIS 49 CobaCyte 49 Selective Electrochemical Tumor Ablation 49 therapeutic peptide 49 Curaxin CBLC# 49 Nautilus Biotech 49 Symadex 49 PORxin TM 49 BHT DNA 49 OSI Prosidion 49 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 49 CCX# 49 molecular chaperone 49 ATL# [002] 49 huC# DM4 49 Hedgehog signaling pathway 49 Panzem R NCD 49 NeoLipid R 49 nucleoside 49 resolvins 49 UltiMAb 49 targeted radiotherapeutics 49 gallium containing 49 iCo 49 OX1 49 Receptors GPCRs 49 ANAVEX #-# [003] 49 Clavis Pharma 49 SMARTICLES ® 49 microRNA 49 RenaZorb TM 49 inhaled formulation 49 NASDAQ FLML 49 activate SIRT1 49 tubulin inhibitor 49 Protein Kinase C 49 immune modulators 49 biochemical profiling 49 Hemopurifier R 49 anti infective compounds 49 ERYtech Pharma 49 2 inhibitor CYT# 49 RONDEL 49 Eligen ® Technology 49 NOXXON 49 Aviptadil 49 OTCBB NVLT biopharmaceutical 49 immunotherapeutic vaccine 49 TG# [003] 49 torezolid phosphate 49 mitotic kinesins 49 myelofibrosis polycythemia vera 49 Vaccinex 49 HIV integrase inhibitors 49 rFVIIIFc 49 gene therapy 49 Board LWLG technology 49 product platforms AZX# 49 NASDAQ CYPB 49 OTC BB PVCT 49 Stemgent 49 Hemopurifier ® 49 AKIP TM 49 Preclinical studies suggest 49 HDAC inhibitors 49 Transdel TM 49 punctal plugs 49 relapsing forms 49 Domantis 49 nitric oxide donating prostaglandin 49 ANG# 49 Angiochem 49 biopharmaceutical 49 iPSC 49 OTCBB DORB DOR 49 XmAb 49 gene silencing 49 investigational monoclonal antibody 49 Phylogica 49 ANTISENILIN ® 49 myeloproliferative disorders 49 JAK3 49 Diasome 49 NASDAQ INGN 49 Ustekinumab 49 Cyclooxygenase Inhibiting Nitric Oxide 49 PDE7 49 therapeutic mAbs 49 rheumatoid arthritis multiple sclerosis 49 OGeS 49 HuCAL 49 Genasense evaluating 49 IMiDs ® 49 drug ISA# 49 Intradigm 48 DepoVax 48 RXi 48 PKC# 48 Intradigm Corporation 48 ANAVEX 48 Javelin Pharmaceuticals AMEX JAV 48 OMAPRO 48 CEQ# 48 retinal disorders 48 proven DuraSite ® 48 ATL# [001] 48 antitumoral 48 angiogenesis inhibitor 48 Elixir Pharmaceuticals 48 botanical therapeutics 48 BGC# 48 Promedior 48 Cellgate Inc. 48 Anticalins ® 48 Inc. AMEX YMI 48 PRTX 48 ImmunoCellular 48 Onno van de Stolpe 48 Romidepsin 48 Sangamo ZFP technology 48 DiLA2 platform 48 IMA# 48 R#/MEM # 48 oral anticancer 48 Cerashield 48 Affibody ® molecules 48 Sym# 48 Personalized Immunotherapy 48 Ampligen ® 48 BiTE antibody 48 Prime BioResearch 48 elotuzumab 48 PsychoGenics 48 INS# [001] 48 AEMD 48 oral salmon calcitonin 48 commercialize deforolimus 48 Squalamine 48 Cephalon Oncology 48 AMEX INO 48 monoclonal antibody MAb 48 NASDAQ BTRX pharmaceutical 48 carbon nanomaterials 48 Stemedica Cell Technologies 48 target Galectin receptors 48 HGS# 48 VEGF Trap 48 inhibit KSP 48 Amarantus 48 Acuity Pharmaceuticals 48 BYETTA ® 48 Orexo 48 NYSE Amex RGN 48 HQK 48 Spiegelmers ® 48 SPC# [001] 48 obatoclax 48 acne impetigo 48 tyrosine kinase inhibitor 48 AlphaRx 48 PXD# 48 Anticalins R 48 Alnylam Pharmaceuticals Inc. 48 Valortim 48 diabetic neuropathic pain 48 carbohydrate polymers 48 Aileron Therapeutics 48 Cyclosert TM 48 NEUMUNE 48 NexACT ® technology 48 CINTREDEKIN BESUDOTOX 48 Synavive 48 Affimed 48 Zingo TM 48 Company Euronext OCTO 48 Kevetrin ™ 48 Synageva 48 Kamada AAT 48 human monoclonal antibody 48 M2 subunit 48 Nasdaq IDRA today 48 Regenerative medicine 48 acetonide FA 48 Hemopurifier TM 48 quinolone 48 Mersana 48 stapled peptides 48 recombinant vaccines 48 MVA BN R 48 Inc. Nasdaq INFI 48 selective kinase inhibitor 48 anti infective treatments 48 small molecule PEGylation 48 PHX# 48 Protalex Inc. 48 Ron Bentsur 48 PEG SN# 48 RNA Interference RNAi 48 Rebif ® 48 dermatology therapies 48 Fibroblast Growth Factor Receptor 48 TTR amyloidosis 48 PRNewswire FirstCall Nastech Pharmaceutical 48 identify protein biomarkers 48 Neuraltus 48 Bavarian Nordic patented 48 DPP4 inhibitor 48 Tekmira SNALP stable 48 viral diseases 48 ZFN technology 48 topical anti infective 48 GLPG# 48 predictive biomarkers 48 Xanafide 48 vosaroxin 48 voreloxin 48 intracellular signaling pathways 48 Spiro Rombotis President 48 lipid particles SNALP 48 ALN RSV# 48 protein kinase inhibitors 48 New Chemical Entities 48 Ii protein 48 biomarkers 48 Poly ICR 48 Achaogen 48 NYSE Amex PBTH 48 phase IIa clinical 48 MDV# 48 HspE7 48 VaxImmune 48 DNAi 48 Jennerex 48 PBT2 48 Oxford BioMedica 48 Inovio Biomedical Corporation 48 OMP #M# 48 Tumor Necrosis Factor 48 PDE4 inhibitors 48 NanoViricides Inc. 48 sulfonylhydrazine class 48 Zysolin TM 48 Interferon alpha 48 Aegera 48 conventional monoclonal antibodies 48 CBLB# 48 OvaRex R 48 Nasdaq MITI biopharmaceutical 48 EyeGate ® II 48 NASDAQ LGND 48 Oramed 48 CR# vcMMAE 48 KL4 surfactant 48 nebulized budesonide 48 Captisol enabled 48 tkRNAi technology 48 signal transduction inhibitors 48 solid tumors 48 Diatos 48 Exelixis XL# 48 DCVax R 48 IIB ActRIIB 48 prodrugs 48 PI3K delta 48 VEGF receptor 48 Actemra tocilizumab 48 nonclinical studies 48 preclinical efficacy 48 ARIAD 48 Affinium Pharmaceuticals 48 relapsed leukemia 48 BRAF kinase 48 Can Fite 48 RXi proprietary 48 bafetinib 48 sodium glucose cotransporter 48 proteomics bioinformatics 48 Ophthotech 48 nanoviricide 48 Autoimmune diseases 48 NNR Therapeutics TM 48 pralatrexate 48 protease inhibitor telaprevir 48 AKIP 48 NASDAQ ALTH biopharmaceutical 48 TKB# 48 FoldRx Pharmaceuticals Inc. 48 anti infectives 48 Janus kinase 48 Viamet 48 immunomodulators 48 TRACON Pharmaceuticals 48 Metaphore 48 prostones 48 antibacterial therapeutics 48 XOMA 48 Tumor Activated Prodrug TAP 48 molecularly targeted therapies 48 Vascular Endothelial Growth 48 NASDAQ AVII developer 48 GRN# 48 GlycoMimetics 48 CollaFix ™ 48 DuraSite 48 GENova 48 Neurogen Corporation 48 vinca alkaloids 48 DETERx ™ 48 synthetic genomics 48 relapsed multiple myeloma 48 AvalonRx R 48 oncolytic vaccine 48 Merck Serono division 48 IgG1 antibody 48 ThermoDox R 48 Santaris Pharma 48 Chemophase 48 ZFP Therapeutics 48 Kolltan Pharmaceuticals 48 TTR gene 48 immuno inflammatory 48 Nasdaq OMER 48 CFFT 48 bexarotene 48 ImmunoCellular Therapeutics 48 Betrixaban 48 TapImmune 48 Allovectin 7 R 48 INT# [002] 48 Atiprimod 48 J. Donald deBethizy 48 Epiphany Biosciences 48 2DG

Back to home page